TRENDS AND PATTERNS OF BREAST CONSERVATION TREATMENT IN HONG KONG: 1994-2007

被引:16
作者
Yau, Tsz-Kok [1 ]
Soong, Inda S. [1 ]
Sze, Henry [1 ]
Choi, Cheuk-Wai [1 ]
Yeung, Mei-Wan [1 ]
Ng, Wai-Tong [1 ]
Lee, Anne W. M. [1 ]
机构
[1] Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Chaiwan, Hong Kong, Peoples R China
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 74卷 / 01期
关键词
Breast cancer; Conservation; Hong Kong; CANCER PATIENTS; CHINESE WOMEN; STAGE-II; THERAPY; SURGERY; MASTECTOMY; EXPERIENCE; MANAGEMENT; DOCETAXEL; CARCINOMA;
D O I
10.1016/j.ijrobp.2008.07.066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Breast conservation treatment (BCT) was quite unpopular in Hong Kong until the early 1990s, but the trends and patterns of BCT use in the past 14 years have not been studied since. The purpose of this study was to identify the latest trends and patterns. Methods and Materials: All consecutive cases of female breast cancer referred to a community oncology center in Hong Kong between 1994 and 2007 were retrospectively reviewed. Of the 2,375 women with T1-2 invasive breast cancer who underwent surgery, 1,137 (48%) had T1 (:52 cm) disease and 1,238 (52%) had T2 (>2 cm-<= 55 cm) disease. Median patient age was 51 years (range, 24-95 years); 65% patients had their surgery in public hospitals. Results: Of the total patient cohort, 2,153 (91%) patients presented with palpable breast masses and only 104 (4%) with mammographically detected cancers. Overall, 721 (30%) and 1,654 (70%) patients underwent BCT and mastectomy, respectively. There was no significant increase in the BCT rates (31%, SD 5%; p = 0.804) or mammographic detection rates (5%, SD 1%; p = 0.125) in Hong Kong between 1994 and 2007. In multivariate analyses, age <= 50 years (OR 2.479; p < 0.001), mammographically detected tumors (OR 1.868; p = 0.007), T1 tumors (OR 3.159; p < 0.001), surgeries in private hospitals (OR 1.288; p = 0.018), and negative nodal status (OR 1.886; p < 0.001) were independent factors predictive of a higher likelihood of a woman having BCT. Conclusions: Our results indicate a satisfactory acceptance of BCT by patients who are young and have small tumors, node-negative disease, or surgery in private hospitals. However, the continuing unpopularity of breast screening is likely a major factor limiting the broad use of BCT. (C) 2009 Elsevier Inc.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 25 条
[1]   Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004 [J].
Ahn, Sei Hyun ;
Yoo, Keun Young .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 99 (02) :209-214
[2]   The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27 [J].
Bear, HD ;
Anderson, S ;
Brown, A ;
Smith, R ;
Mamounas, EP ;
Fisher, B ;
Margolese, R ;
Theoret, H ;
Soran, A ;
Wickerham, DL ;
Wolmark, N .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4165-4174
[3]   Case-mix fails to explain variation in mastectomy rates: management of screen-detected breast cancer in a UK region 1997-2003 [J].
Caldon, LJM ;
Walters, SJ ;
Reed, JA ;
Murphy, A ;
Worley, A ;
Reed, MWR .
BRITISH JOURNAL OF CANCER, 2005, 92 (01) :55-59
[4]  
CHEUNG FY, 2005, P 13 ANN SCI M HONG
[5]   Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management [J].
Chua, MST ;
Mok, TSK ;
Kwan, WH ;
Yeo, W ;
Zee, B .
BREAST JOURNAL, 2005, 11 (01) :52-56
[6]   Multicenter phase II trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage II or III breast cancer: Results of the GETN(A)-1 trial [J].
Coudert, Bruno P. ;
Largillier, Remy ;
Arnould, Laurent ;
Chollet, Philippe ;
Campone, Mario ;
Coeffic, David ;
Priou, Frank ;
Gligorov, Joseph ;
Martin, Xavier ;
Trillet-Lenoir, Veronique ;
Weber, Beatrice ;
Bleuse, Jean Pierre ;
Vasseur, Berangere ;
Serin, Daniel ;
Namer, Moise .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) :2678-2684
[7]  
CROFTS TJ, 1986, HONG KONG PRACT, V8, P1805
[8]   Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].
Fisher, B ;
Bryant, J ;
Wolmark, N ;
Mamounas, E ;
Brown, A ;
Fisher, ER ;
Wickerham, DL ;
Begovic, M ;
DeCillis, A ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV ;
Bear, HD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685
[9]  
Gilligan MA, 2002, MED CARE, V40, P181
[10]  
HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391